Skip to search formSkip to main contentSkip to account menu

blinatumomab 0.035 MG Injection [Blincyto]

Known as: BLINATUMOMAB 12.5 ug in 1 mL INTRAVENOUS INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION [BLINCYTO], Blincyto 0.035 MG Injection, Blincyto 35 MCG Injection 
National Institutes of Health

Related topics

Related topics

8 relations
BlincytoInjectionLysine HydrochloridePolysorbate 80

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2018
2018
INTERMITTENT MOVE BEYOND BLINCYTO
  • 2018
  • Corpus ID: 88501184
A swath of data at ASH shows that companies have been able to move beyond the 28-day continuous dosing of Amgen Inc.’s first…